CIK 0001498382
- Non-accelerated filer
- Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 990360497
- Phone
- +1 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 4 Grant or award President and CEO acquired 400,145 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 55,000 shares at $0.47 ($25,795)
- 4 Open-market buy Chief Financial Officer bought 28,700 shares at $0.68 ($19,430)
- 4 Open-market buy Head of Strategic Partnerships bought 50,000 shares at an average $0.63 ($31,316)
- 4 Open-market buy Director bought 3,000 shares at $0.74 ($2,227)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Conversion Chief Scientific Officer acquired 750 shares (conversion)
- 4 Conversion Chief Financial Officer acquired 938 shares (conversion)
- 4 Conversion Director acquired 325 shares (conversion)
- 4 Other acquisition Director acquired 8 shares (other)
Page 3 of 16 · 307 filings